National Minority Cancer Awareness Week For the past twenty-nine years, the third week in April has been designated as National Minority Cancer Awareness Week. This year, it runs April 10 through April 16. The importance of this week is well explained in the Congressional Record, “While cancer
When the average American thinks of the word “diet,” their mind automatically fills with thoughts of food; the control or lack of control one has when it comes to eating certain foods, and the obvious “is this going to make me gain or lose weight?” While many of us focus on whether the food we are
North Carolina is moving backward in the fight against tobacco use, which continues to be the number one cause of preventable death in our state. According to the 2013 North Carolina Youth Tobacco Survey (the 2015 data is not yet available), cigarette use among high schoolers had declined
In honor of Valentine’s Day, we would like to recognize the important role loved ones play in our lives. Caregivers can come in many different ways, spouses, friends, family members, or even volunteers just to name a few. Today, we are recognizing one special caregiver. Survivor, Justin Brian
Recently, the White House announced a new 1 billion program to hopefully defeat cancer called the National Cancer Moonshot. This is exciting news to us here at the Lung Cancer Initiative of North Carolina. Whether you know somebody who has been affected by cancer or you yourself have been through
In Honor of National Radon Action Month, the Lung Cancer Initiative of N.C. has teamed up with the N.C. Radon Program to provide free short-term radon test kits. Radon is the second-leading cause of lung cancer in the United States; the Initiative wants to educate about the dangers of
Every person with lung cancer deserves a brighter tomorrow. Please consider a tax-deductible year end gift to help us provide hope. Your support has helped make the Lung Cancer Initiative of North Carolina the leading lung cancer organization in the state. We are so grateful to you for
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Alecensa® (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have
Tax Exemption Removal Follow-Up: We Did It! Early Friday morning, legislators gave final approval to a state budget that preserves nonprofit sales tax refunds and the charitable deduction on state taxes. Thank you for being part of the united voice for nonprofits from across the state.
You are invited to AWARE for All- The Triangle, a free featuring a health fair and informative presentation about clinical research participation. Participation in clinical trials is an important step in developing life-saving medicines and treatments. Unfortunately, many people know
© 2020 Lung Cancer Initiative of North Carolina, All Rights Reserved. | Privacy Policy | Site Map
